Cyprotex - An Evotec Company
Cyprotex specialises in in vitro and in silico ADME-Tox services. This includes in vitro ADME screening to support discovery projects, regulatory in vitro ADME and DDI studies during pre-clinical and clinical development, specialist mechanistic in vitro human and animal toxicity models (e.g., 3D models and MEA electrophysiology) and PBPK/QSAR modelling expertise.
Our dedicated team of specialists are on hand to take your enquiries:
- Daniel Gliesche, Director, Business Development - Germany/ Austria/ Scandinavia: +49 160 1533264
- David Cerny, Senior Director, Business Development - West Coast US: +1 609 356 6326
- Erin Koester, Business Development Manager - East Coast US: +1 609 686 3194
- Felix von Haniel, SVP, Business Development - General enquiries/Framingham opening 27th April/Basel workshop 4th May
- Oksana Nikolayenko, Director, Business Development - UK/ Ire/ Spain/ Portugal/ Eastern EU: +44 7706 350245
- Ralf Geiben Lynn, Senior Director, Business Development - East Coast US: +1 617 712 9748
- Tim Potter, VP, Business Development - Switzerland/ France/ Benelux/ Italy/ Israel and Asia-Pacific/ Basel workshop 4th May: +44 7761 512324
- Tom Kaczka, Business Development Manager - West Coast US: +1 609 509 1708
TOP